骨髓抑制

The chemotherapy caused myelosuppression, leading to severe fatigue and low white blood cell count.
化疗导致骨髓抑制，表现为极度疲劳和白细胞计数下降。
The patient is experiencing myelosuppression due to the side effects of the cancer treatment.
病人因癌症治疗的副作用出现了骨髓抑制。
Myelosuppression is a common complication in patients undergoing stem cell transplants.
骨髓抑制是干细胞移植患者常见的并发症。
The doctor prescribed medications to boost the patient's bone marrow and overcome myelosuppression.
医生开处方药物以刺激骨髓恢复，以对抗骨髓抑制。
The patient's immune system was weakened by the myelosuppression, making them more susceptible to infections.
由于骨髓抑制，病人的免疫系统减弱，容易感染。
The recovery from leukemia often includes managing myelosuppression during chemotherapy.
白血病康复过程中，管理化疗引起的骨髓抑制是一个重要环节。
The use of low-dose chemotherapy can help minimize myelosuppression.
使用小剂量化疗可以减少骨髓抑制的风险。
Prevention of infection is crucial in managing myelosuppression, as a weakened immune system can exacerbate the condition.
预防感染对于管理骨髓抑制至关重要，因为虚弱的免疫系统会加重病情。
Post-transplant patients often require close monitoring for myelosuppression recovery.
移植后患者需要密切监测以恢复骨髓功能。
New research aims to develop targeted therapies to alleviate the symptoms and mitigate myelosuppression.
新的研究致力于开发针对性疗法来缓解症状并减轻骨髓抑制。